Legal complexities for offshore early-stage life sciences companies considering Australia’s R&D Tax Incentive scheme

The R&D Tax Incentive can provide a significant funding boost to early-stage companies in the life sciences sector and, for entities with an aggregated group turnover of less than A$20 million per annum, a cashflow boost. By conducting R&D activities in Australia, eligible companies can overcome many of the cost and funding challenges facing early-stage companies in the life sciences secto…